Improved serological response to human diploid cell rabies vaccine when given simultaneously with antirabies hyperimmune globulin

Archives of Medical Research

Volumn 30, Issue 4, 1999, Pages 332-337

  Navarrete Navarro, Susana ^a   Aguilar Setién, Alvaro ^a   Avila Figueroa, Carlos ^b   Hernández Sierra, Francisco ^a   Santos Preciado, José Ignacio ^c,d  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^c SECRETARÍA DE SALUD   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Diploid cells; Rabies; Vaccine

Indexed keywords

RABIES IMMUNOGLOBULIN; RABIES VACCINE;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG INDUCED DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; FOLLOW UP; HUMAN; IMMUNOPROPHYLAXIS; INFECTION PREVENTION; INTRAMUSCULAR DRUG ADMINISTRATION; LYMPHADENOPATHY; PAIN; RABIES; VACCINATION;

EID: 0033167030     PISSN: 01880128     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0188-0128(99)00036-6     Document Type: Article

References (24)

1. Nicholson K. Modern vaccines. Lancet. 335:1990;1201.
2. Nicholson K., Burney M., Ali S., Perkins F. Stability of human diploid cell strain rabies vaccine at high ambient temperature. JAMA. 249:1983;2147.
3. Roumiantzeff M., Ajjan N., Brache R., Fournier P., Montagnon B., Trotemann P., Vincent F.J. Rabies vaccine produced in cell culture. production, control and clinical results Kurstak E. Applied Virology. 1984;Academic Press, New York. 241.p.
4. Jiménez C.A., Torres C.J.L., López M.S. Situación epidemiológica de la rabia a nivel mundial y en México. Enferm Infecc Microbiol Clin. 16:1996;29.
5. Sistema Nacional de Vigilancia Epidemiológica Distribución mensual de casos de rabia. Bol Epidemiol. 15(31):1998;14.
6. Kumate R.J. Rabia. Kumate R.J., Gutiérrez G., Muñoz H.O., Santos Preciado J.I. Manual de Infectología Clínica. 15th ed:1998;Méndez Editores, Mexico, D.F. 231.p.
7. Warrel M.J., Warrel D.A., Chanthavanich P., Sinhaseni A., Pouradier-Duteil X., Nicholson K.G., Suntharasamai P., Viravan C.H., Chiewbambroongkiat M.K., Xueref C., Udomsakdi D. Economical multiple-site intradermal immunisation with human diploid-cell-strain vaccine is effective for post-exposure rabies prophylaxis. Lancet. 1:1985;1059.
8. Ubol S., Phanuphak P. An effective economical intradermal regimen of human diploid cell rabies vaccination for post-exposure treatment. Clin Exp Immunol. 63:1986;491.
9. Lameshow S., Hosmer D., Klar J., Lwanga S. Adequacy of sample size in health studies. 1992;36 John Wiley and Sons, Chichester, UK.
10. Perrin P., Versmisse P., Delagneau J.F., Lucas G., Rollin P.E., Sureau P. The influence of the type of immunosorbent on rabies antibody EIA. advantages of purified glycoprotein over whole virus J Biol Stand. 14:1986;95.
11. Atanasiu P., Perrin P., Delagneau J.F. Use of an enzyme immunoassay with protein A for rabies antigen and antibody determination. Dev Biol Stand. 46:1980;207.
12. Atanasiu P., Savy V., Perrin P. Epreuve immunoenzymatique pour la rapide des anticorps antirabiques. Ann Microbiol. 128:1977;489.
13. Swanson M., Rosanoff E., Gurwith M., Deitch M., Schurrenberger P., Reed C. IgE and IgG antibodies to Beta-propiolactone and human serum albumin associated with urticarial reactions to rabies vaccine. J Infect Dis. 155:1987;909.
14. Favoretto S., Carrieri M., Tino M., Assis A., Zanetti C., Pereira O. Reduce schedule of human anti-rabies immunization with Fuenzalida y Palacios vaccine. Rev Inst Med Trop Sao Paulo. 35:1993;281.
15. Nicholson K., Prestage H., Cole P., Turner G., Bauer S. Multisite intradermal antirabies vaccination. Lancet. 2:1981;915.
16. Kieny M.P., Lathe R., Drillien R., Spehner D., Skory S., Schmitt D., Wiktor T., Koprowsky H., Lecocq J.P. Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature. 312:1984;163.
17. Wunderli P., Shaddock J., Schmid D., Miller T., Baer G. The protective role of humoral neutralizing antibody in the NIH potency test for rabies vaccines. Vaccine. 9:1991;639.
18. Briggs D., Schwenke J. Longevity of rabies antibody titre in recipients of human diploid cell rabies vaccine. Vaccine. 10:1992;125.
19. Fishbein D.B., Pacer R.E., Holmes D.F., Ley A.B., Yager P., Tong T.C. Rabies preexposure prophylaxis with human diploid cell rabies vaccine. a dose-response study J Infect Dis. 156:1987;50.
20. Baltazard M., Bahmanyar M., Ghodssi M., Sabeti A., Gajdusek C., Rouzbehie R. Essai practique du serum antirabique chez les mordus par loups enrages. Bull World Health Organ. 13:1995;747.
21. Atanasiu P, Dean D, Habel K, Kaplan M, Koprowski H, Lepine P. Series on Rabies: rabies neutralizing antibody response to different schedules of serum and vaccine inoculation in non-exposed persons. Part 4. Bull World Health Organ 1967;36:361.
22. Mean F., Steck F., Tanner F. Humoral immunity conferred by the HDCS-rabies vaccine Merieux administered after exposure. 151 cases with and without specific immune globulin of human organ Dev Biol Stand. 40:1978;159.
23. Lin F.T., Chen S.B., Wang Y.Z., Sun C.Z., Zeng F.Z., Wang G.F. Use of serum and vaccine in combination for prophylaxis following exposure to rabies. Rev Infect Dis. 10(Suppl 4):1988;S766.
24. Roitt I. Essential immunology. 8th ed:1994;43 Blackwell Scientific Publications, Oxford.